Primary Malignant Liver Neoplasm — Trials

Primary Malignant Liver Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,486 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 807
Recruiting: 471
Ph III recruiting: 42
Growth YoY: +1.5%
Industry share: 21%
Top sponsor: Sun Yat-sen University
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (402)

clinicaltrialsPublishedShowing 151–200 of 412 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06239194	Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors	recruiting	Phase 1 / Phase 2	285	ModeX Therapeutics, An OPKO Health CompanyINDUSTRY	1	May 6, 2026	clinicaltrials
NCT07570849	Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic Cholangiocarcinoma	recruiting	Phase 2	35	Shanghai Zhongshan HospitalOTHER	1	May 6, 2026	clinicaltrials